Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
LYON, France, May 2, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018, after the close of the financial markets on Monday, May 14, 2018.
An accompanying conference call will be conducted by Philippe Chauveau, Chairman of the Board; Marc Oczachowski, Chief Executive Officer; and François Dietsch, Chief Financial Officer, to review the results. The call will be held at 8:30 AM ET, on Tuesday, May 15, 2018. Please refer to the information below for conference call dial-in information and webcast registration.
Conference Call & Webcast
Tuesday, May 15, 2018 @ 8:30am Eastern Time
Domestic: 866-548-4713
International 323-794-2093
Passcode: 9225280
Webcast: http://public.viavid.com/index.php?id=129164
Replays, Available through May 29, 2018:
Domestic: 844-512-2921
International: 412-317-6671
Replay PIN: 9225280
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® (currently pending FDA clearance) in 2013 as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.
CONTACTS:
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 72
[email protected]
Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
[email protected]
